Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
5.81
+0.83 (16.67%)
At close: Apr 8, 2026, 4:00 PM EDT
5.84
+0.03 (0.52%)
After-hours: Apr 8, 2026, 6:16 PM EDT
Tevogen Bio Holdings Employees
Tevogen Bio Holdings had 18 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
18
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,490,302
Market Cap
24.19M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 18 | 0 | - |
| Dec 31, 2024 | 18 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Boundless Bio | 28 |
| NeuroSense Therapeutics | 17 |
| Barinthus Biotherapeutics | 14 |
| Serina Therapeutics | 13 |
| Skye Bioscience | 12 |
| Neuphoria Therapeutics | 8 |
| Exicure | 8 |
| Lexaria Bioscience | 7 |
TVGN News
- 13 days ago - Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth - GlobeNewsWire
- 14 days ago - Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 21 days ago - Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026) - GlobeNewsWire
- 26 days ago - Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization - GlobeNewsWire
- 26 days ago - Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure - GlobeNewsWire
- 4 weeks ago - Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform - GlobeNewsWire
- 4 weeks ago - Tevogen Names Leadership Team to Execute Diversified Growth Strategy - GlobeNewsWire
- 4 weeks ago - Letter to Shareholders from CEO Dr. Ryan Saadi - GlobeNewsWire